Iovance Biotherapeutics
IOVA
IOVA
217 hedge funds and large institutions have $1.1B invested in Iovance Biotherapeutics in 2022 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 83 increasing their positions, 71 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
25% less capital invested
Capital invested by funds: $1.45B → $1.1B (-$356M)
45% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 47
Holders
217
Holding in Top 10
1
Calls
$9.1M
Puts
$3.82M
Top Buyers
| 1 | +$76.7M | |
| 2 | +$30.6M | |
| 3 | +$25.1M | |
| 4 |
Renaissance Technologies
New York
|
+$15.3M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$11.9M |
Top Sellers
| 1 | -$22.6M | |
| 2 | -$13.2M | |
| 3 | -$12.8M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$12M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$11.1M |